Cargando…

Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective

BACKGROUND: The burden of pneumococcal disease in adults aged 65 years and older in Australia is not well defined. This retrospective cross-sectional study calculated rates for pneumococcal pneumonia using data from the Australian Institute of Health and Welfare and from the Bettering Evaluation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Earle, Kylie, Williams, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471924/ https://www.ncbi.nlm.nih.gov/pubmed/28702288 http://dx.doi.org/10.1186/s41479-016-0008-8

Ejemplares similares

2205. Clinical Burden of Pneumococcal Disease in US Adults Aged 65 Years and Above with Chronic or Immunocompromising Conditions
por: Deb, Arijita, et al.
Publicado: (2019)

Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice
por: Frank, Oliver, et al.
Publicado: (2020)

Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
por: Biyik, M. V., et al.
Publicado: (2020)

Economic Burden of Pneumococcal Disease in Individuals Aged 15 Years and Older in the Liguria Region of Italy
por: Astengo, Matteo, et al.
Publicado: (2021)

Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany
por: Deb, Arijita, et al.
Publicado: (2022)

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
por: Almendares, Olivia M, et al.
Publicado: (2018)

Burden of disease associated with lower levels of income among US adults aged 65 and older
por: Lubetkin, Erica I, et al.
Publicado: (2017)

596 Potential public health impact of 13-valent pneumococcal conjugate vaccine use among US adults 65 years of age or older
por: Pilishvili, Tamara, et al.
Publicado: (2014)

Evaluating Potential Impacts of a Preferential Vaccine Recommendation for Adults 65 Years of Age and Older on US Influenza Burden
por: Morris, Sinead E., et al.
Publicado: (2023)

Gender and Age Differences in Anthropometric Characteristics of Taiwanese Older Adults Aged 65 Years and Older
por: Su, Yan-Jhu, et al.
Publicado: (2023)

Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
por: Black, Carla L., et al.
Publicado: (2017)

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection
por: Marbaix, Sophie, et al.
Publicado: (2018)

Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
por: Thomas, Roger E.
Publicado: (2021)

Economic burden of pneumococcal infections in children under 5 years of age
por: Ceyhan, Mehmet, et al.
Publicado: (2017)

Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia
por: Moa, Aye M., et al.
Publicado: (2021)

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
por: Pilishvili, Tamara, et al.
Publicado: (2018)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Tomczyk, Sara, et al.
Publicado: (2014)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Matanock, Almea, et al.
Publicado: (2019)

Tuberculosis Disease Among Adults Aged 65 Years and Older: Alameda County, California, 2016–2019
por: Wu, Iris L, et al.
Publicado: (2022)

Association of Frailty and Suicide in Adults 65 Years and Older
por: Kuffel, Randall, et al.
Publicado: (2021)

1404. Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
por: Lapidot, Rotem, et al.
Publicado: (2020)

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
por: Nielsen, Katrine Finderup, et al.
Publicado: (2022)

Association of Diet Quality With Longevity and Successful Aging in Israeli Adults 65 Years or Older
por: Goshen, Abigail, et al.
Publicado: (2022)

1173. Risk of Pneumococcal Disease and Rate of Pneumococcal Vaccination Among Medicare Beneficiaries Aged 65 Years and Older Residing in Long-Term Care Facilities — United States, September 1, 2014 – December 31, 2019
por: Kobyashi, Miwako, et al.
Publicado: (2023)

2593. Epidemiology and Clinical Burden of Invasive Pneumococcal Disease in Older Adults in the City of São Paulo, Brazil
por: Figueiredo, Licieri, et al.
Publicado: (2023)

1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
por: Schirmer, Patricia, et al.
Publicado: (2023)

744. Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine and Influenza Vaccine Against Pneumococcal Pneumonia Among Elderly Patients Aged 65 Years and Older in the Republic of Korea: A Case–Control Study
por: Kim, Jong Hun, et al.
Publicado: (2018)

Laparoscopic Surgery in Elderly Patients Aged 65 Years and Older with Gynecologic Disease
por: Kanasaki, Haruhiko, et al.
Publicado: (2012)

Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study
por: Zhang, Dongmu, et al.
Publicado: (2018)

Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia
por: Narváez, Paula O., et al.
Publicado: (2021)

Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination
por: Chikhaoui, Amar, et al.
Publicado: (2022)

Pneumococcal colonization in older adults
por: Esposito, Susanna, et al.
Publicado: (2016)

2219. Evaluation of Medicare Claims to Assess Burden of Pertussis Disease in Persons Aged ≥65 Years
por: Havers, Fiona, et al.
Publicado: (2019)

A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014
por: Hamaguchi, Megumi, et al.
Publicado: (2023)

The burden of pneumonia in children: an Australian perspective
por: Burgner, David, et al.
Publicado: (2005)

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
por: Choi, Min Joo, et al.
Publicado: (2022)

Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age
por: Wasserman, Matt D., et al.
Publicado: (2021)

Diet Quality Is Associated with All-Cause Mortality in Adults Aged 65 Years and Older(2)
por: McNaughton, Sarah A., et al.
Publicado: (2012)

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
por: Shiragami, Makoto, et al.
Publicado: (2019)

Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
por: Li, Xiuyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_97h3u9g3l97hd2nbj2ija9n0v4